Apogee Therapeutics, Inc.

Historical 13F Holders

Symbol
APGE
CUSIP
03770N101
All holders as of
Q3 2026
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Shares Held, Excluding Options
Total Filers

13D/G Filers

Each filer's latest filing for 03770N101 since 12/18/2024, largest first.

Filer % of Class Filed
BlackRock, Inc. 13G/A 5.5% 7/16/2025
Event 6/30/2025
Under 5%, checked the "5 percent or less" box, or amended by a later filing (8)
RTW Investments, LP 13G/A
4.9% 2/17/2026
Event 12/31/2025
Driehaus Capital Management LLC 13G/A 4.7% 11/14/2025
Event 9/30/2025
FMR LLC 13G/A
4.0% 7/8/2026
Event 6/30/2026
T. Rowe Price Investment Management, Inc. 13G/A 1.3% 7/8/2026
Event 6/30/2026
Wellington Management Group LLP 13G/A
0.9% 7/8/2026
Event 6/30/2026
Fairmount Funds Management LLC 13D/A
0% 9/3/2026
Event 9/3/2026
Vanguard Group Inc 13G/A 0% 3/26/2026
Event 3/13/2026
Venrock Healthcare Capital Partners III, L.P. 13D/A
0% 9/8/2026
Event 9/3/2026

13F Holders by Quarter

Period Filers Shares, Excl. Options Value, Excl. Options
2026 Q3 2 8.21 k $334k
2026 Q2 298 71.0 M $9.38B
2026 Q1 230 79.1 M $6.64B
2025 Q4 211 71.3 M $5.34B
2025 Q3 174 59.6 M $2.37B
2025 Q2 184 57.8 M $2.51B
2025 Q1 172 61.5 M $2.30B
2024 Q4 160 57.9 M $2.62B
2024 Q3 142 56.1 M $3.29B
2024 Q2 140 54.2 M $2.13B
2024 Q1 142 52.9 M $3.52B
2023 Q4 86 41.8 M $1.16B
2023 Q3 74 40.1 M $849M